NEW YORK, Sept. 4, 2013 /PRNewswire/ -- Harwood Feffer
LLP (www.hfesq.com) is investigating potential claims against the
board of directors of Rochester Medical Corporation ("Rochester
Medical" or the "Company") (NASDAQ: ROCM) concerning the proposed
acquisition of the Company by C.R. Bard ("Bard").
(Logo:
http://photos.prnewswire.com/prnh/20120215/MM54604LOGO )
On September 4, 2013, Rochester
Medical announced that it had entered into a definitive agreement
pursuant to which the Company will be acquired by Bard. Under
the terms of the agreement, Rochester Medical shareholders will
receive $20.00 for each Bard share
owned.
Our investigation concerns whether the Rochester Medical board
of directors is fulfilling its fiduciary duties, maximizing the
value of the Company, disclosing all material benefits and costs,
and obtaining full and fair consideration for Company
shareholders.
If you own Rochester Medical shares and wish to discuss this
matter with us, or have any questions concerning your rights and
interests with regard to this matter, please contact:
Benjamin Sachs-Michaels, Esq.
Robert I. Harwood, Esq.
Harwood Feffer LLP
488 Madison Avenue
New York, New York 10022
Phone Numbers: (877) 935-7400
(212)935-7400
Email: bsachsmichaels@hfesq.com
Website: http://www.hfesq.com
Harwood Feffer has been
representing individual and institutional investors for many years,
serving as lead counsel in numerous cases in federal and state
courts. Please visit the Harwood Feffer LLP website
(http://www.hfesq.com) for more information about the firm.
Attorney Advertising © 2013 Harwood Feffer LLP. The law firm
responsible for this advertisement is Harwood Feffer LLP
(www.hfesq.com). Prior results do not guarantee or predict a
similar outcome with respect to any future matter.
SOURCE Harwood Feffer LLP